0

Journal Articles

in Diabetes Mellitus Treatment
 41-60 of 102 Articles
Original Contribution |  April 15, 2009 FREE
C-Peptide Levels and Insulin Independence Following Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation in Newly Diagnosed Type 1 Diabetes Mellitus
Carlos E. B. Couri, MD, PhD; Maria C. B. Oliveira, MD; Ana B. P. L. Stracieri, MD, PhD; et al.
JAMA. 2009;301(15):1573-1579. doi:10.1001/jama.2009.470.
Commentary |  January 14, 2009
Sliding Scale Insulin—Time to Stop Sliding
Irl B. Hirsch, MD
JAMA. 2009;301(2):213-214. doi:10.1001/jama.2008.943.
Commentary |  November 05, 2008
Glucose Lowering to Control Macrovascular Disease in Type 2 Diabetes:  Treating the Wrong Surrogate End Point?
Mark O. Goodarzi, MD, PhD; Bruce M. Psaty, MD, PhD
JAMA. 2008;300(17):2051-2053. doi:10.1001/jama.2008.510.
Lab, Field, and Clinic |  November 05, 2008
Adult Pancreatic Cells “Reprogrammed” Into Rarer Insulin-Producing Cells
Tracy Hampton, PhD
JAMA. 2008;300(17):1988. doi:10.1001/jama.2008.534.
Health Agencies Update |  September 24, 2008
Exenatide Risk
Bridget M. Kuehn
JAMA. 2008;300(12):1403. doi:10.1001/jama.300.12.1403-c.
Caring for the Critically Ill Patient |  August 27, 2008 FREE
Benefits and Risks of Tight Glucose Control in Critically Ill Adults:  A Meta-analysis
Renda Soylemez Wiener, MD, MPH; Daniel C. Wiener, MD; Robin J. Larson, MD, MPH
JAMA. 2008;300(8):933-944. doi:10.1001/jama.300.8.933.
INCLUDES: CME
Commentary |  August 27, 2008
Opportunities for Enhancing the FDA Guidance on Pharmacovigilance
Bruce M. Psaty, MD, PhD; Jan P. Vandenbroucke, MD, PhD
JAMA. 2008;300(8):952-954. doi:10.1001/jama.300.8.952.
Editorial |  August 27, 2008
Tight Glycemic Control in Critically Ill Adults
Simon Finfer, MBBS, FJFICM; Anthony Delaney, MBBS, FJFICM
JAMA. 2008;300(8):963-965. doi:10.1001/jama.300.8.963.
Medical News & Perspectives |  April 09, 2008
Scientists Find Clues to Glucose Intolerance
Tracy Hampton, PhD
JAMA. 2008;299(14):1654. doi:10.1001/jama.299.14.1654.
Capitol Health Call |  April 09, 2008
Surrogate End Points Queried
Mike Mitka
JAMA. 2008;299(14):1657. doi:10.1001/jama.299.14.1657-a.
Original Contribution |  April 02, 2008 FREE
Comparison of Pioglitazone vs Glimepiride on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes:  The PERISCOPE Randomized Controlled Trial
Steven E. Nissen, MD; Stephen J. Nicholls, MBBS, PhD; Kathy Wolski, MPH; et al.
JAMA. 2008;299(13):1561-1573. doi:10.1001/jama.299.13.1561.
Health Agencies Update |  December 26, 2007
FDA Rosiglitazone Warning
JAMA. 2007;298(24):2858. doi:10.1001/jama.298.24.2858-a.
Original Contribution |  December 12, 2007 FREE
Thiazolidinediones and Cardiovascular Outcomes in Older Patients With Diabetes
Lorraine L. Lipscombe, MD, MSc; Tara Gomes, MHSc; Linda E. Lévesque, BScPhm, MSc; et al.
JAMA. 2007;298(22):2634-2643. doi:10.1001/jama.298.22.2634.
Original Contribution |  November 28, 2007 FREE
Glucose-Insulin-Potassium Therapy in Patients With ST-Segment Elevation Myocardial Infarction
Rafael Díaz, MD; Abhinav Goyal, MD, MHS; Shamir R. Mehta, MD, MSc; et al.
JAMA. 2007;298(20):2399-2405. doi:10.1001/jama.298.20.2399.
Medical News and Perspectives |  November 21, 2007
Monitoring Glycemic Control in Diabetes
JAMA. 2007;298(19):2252. doi:10.1001/jama.298.19.2252.
Editorial |  September 12, 2007
Cardiovascular Risk and the Thiazolidinediones:  Déjà Vu All Over Again?
Daniel H. Solomon, MD, MPH; Wolfgang C. Winkelmayer, MD, ScD
JAMA. 2007;298(10):1216-1218. doi:10.1001/jama.298.10.1216.
Medical News and Perspectives |  September 12, 2007
MI Risks Linked to Rosiglitazone
JAMA. 2007;298(10):1147-1151. doi:10.1001/jama.298.10.1149.
Review |  September 12, 2007 FREE
Pioglitazone and Risk of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus:  A Meta-analysis of Randomized Trials
A. Michael Lincoff, MD; Kathy Wolski, MPH; Stephen J. Nicholls, MBBS, PhD; et al.
JAMA. 2007;298(10):1180-1188. doi:10.1001/jama.298.10.1180.
Review |  September 12, 2007 FREE
Long-term Risk of Cardiovascular Events With Rosiglitazone:  A Meta-analysis
Sonal Singh, MD; Yoon K. Loke, MBBS, MD; Curt D. Furberg, MD, PhD
JAMA. 2007;298(10):1189-1195. doi:10.1001/jama.298.10.1189.
Original Contribution |  January 17, 2007 FREE
Risk Factors for Early Myocardial Infarction in South Asians Compared With Individuals in Other Countries
Prashant Joshi, MD; Shofiqul Islam, MSc; Prem Pais, MD; et al.
JAMA. 2007;297(3):286-294. doi:10.1001/jama.297.3.286.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Viewpoint  |  May 13, 2013
Adulterated Sexual Enhancement Supplements:  More Than Mojo
Pieter A. Cohen, MD; Bastiaan J. Venhuis, PhD
JAMA Internal Medicine
Editorial  |  April 22, 2013
Trust in the Medical Literature—and Viewpoints in JAMA Internal Medicine
Robert Steinbrook, MD; Rita F. Redberg, MD, MSc
JAMA Internal Medicine
Original Investigation  |  February 25, 2013
Glucagonlike Peptide 1–Based Therapies and Risk of Hospitalization for Acute Pancreatitis in Type 2 Diabetes Mellitus:  A Population-Based Matched Case-Control Study
Sonal Singh, MD, MPH; Hsien-Yen Chang, PhD; Thomas M. Richards, MS; et al.
JAMA Internal Medicine
Invited Commentary  |  March 5, 2013
Glucagonlike Peptide 1–Based Drugs and Pancreatitis:  Clarity at Last, but What About Pancreatic Cancer?
Comment on “Glucagonlike Peptide 1–Based Therapies and Risk of Hospitalization for Acute Pancreatitis in Type 2 Diabetes Mellitus”
Belinda Gier, PhD; Peter C. Butler, MD
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems